FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 65 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $562,000 | +136.1% | 168,778 | +68.8% | 0.04% | +150.0% |
| Q2 2019 | $238,000 | -92.9% | 100,000 | -88.8% | 0.02% | -91.5% |
| Q1 2019 | $3,334,000 | +459.4% | 889,000 | +754.8% | 0.19% | +347.6% |
| Q3 2018 | $596,000 | -65.9% | 104,000 | -34.1% | 0.04% | -63.8% |
| Q4 2016 | $1,750,000 | -51.3% | 157,700 | -59.4% | 0.12% | -42.9% |
| Q3 2016 | $3,593,000 | +14.0% | 388,000 | -21.9% | 0.20% | +23.0% |
| Q2 2016 | $3,153,000 | -15.0% | 496,547 | -12.8% | 0.16% | -28.3% |
| Q1 2016 | $3,711,000 | -21.1% | 569,180 | -1.9% | 0.23% | -52.6% |
| Q4 2015 | $4,704,000 | +35.2% | 580,000 | +22.2% | 0.48% | +62.8% |
| Q3 2015 | $3,480,000 | -16.2% | 474,810 | +17.2% | 0.30% | +18.3% |
| Q2 2015 | $4,151,000 | – | 405,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |